| Year |
Citation |
Score |
| 2023 |
Lin W, Singh V, Springer R, Choonoo G, Gupta N, Patel A, Frleta D, Zhong J, Owczarek T, Decker C, Macdonald L, Murphy A, Thurston G, Mohrs M, Ioffe E, et al. Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice. Communications Biology. 6: 447. PMID 37185301 DOI: 10.1038/s42003-023-04812-3 |
0.362 |
|
| 2022 |
Wei J, Montalvo-Ortiz W, Yu L, Krasco A, Olson K, Rizvi S, Fiaschi N, Coetzee S, Wang F, Ullman E, Ahmed HS, Herlihy E, Lee K, Havel L, Potocky T, ... ... Frleta D, et al. CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models. Science Translational Medicine. 14: eabn1082. PMID 36350988 DOI: 10.1126/scitranslmed.abn1082 |
0.374 |
|
| 2009 |
Frleta D, Yu CI, Klechevsky E, Flamar AL, Zurawski G, Banchereau J, Palucka AK. Influenza virus and poly(I:C) inhibit MHC class I-restricted presentation of cell-associated antigens derived from infected dead cells captured by human dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 2766-76. PMID 19234171 DOI: 10.4049/Jimmunol.0801720 |
0.368 |
|
| 2009 |
Frleta D, O'Brien M, Haynes B, Kessler B, Bhardwaj N. P10-05. Suppression of human dendritic cell function during acute HIV infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P136 |
0.327 |
|
| 2003 |
Frleta D, Noelle RJ, Wade WF. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells. Journal of Leukocyte Biology. 74: 1064-73. PMID 12960264 DOI: 10.1189/Jlb.0203062 |
0.372 |
|
| 2003 |
Frleta D, Lin JT, Quezada SA, Wade TK, Barth RJ, Noelle RJ, Wade WF. Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 26: 72-84. PMID 12514431 DOI: 10.1097/00002371-200301000-00008 |
0.405 |
|
| 2001 |
Frleta D, Demian D, Wade WF. Class II-targeted antigen is superior to CD40-targeted antigen at stimulating humoral responses in vivo International Immunopharmacology. 1: 265-275. PMID 11360928 DOI: 10.1016/S1567-5769(00)00032-1 |
0.377 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Yu H, Borsotti C, Schickel JN, Zhu S, Strowig T, Eynon EE, Frleta D, Gurer C, Murphy AJ, Yancopoulos GD, Meffre E, Manz MG, Flavell RA. A novel humanized mouse model with significant improvement of class- switched, antigen-specific antibody production. Blood. PMID 28077418 DOI: 10.1182/Blood-2016-04-709584 |
0.288 |
|
| 2013 |
Ott PA, Henry T, Baranda SJ, Frleta D, Manches O, Bogunovic D, Bhardwaj N. Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties. Cancer Immunology, Immunotherapy : Cii. 62: 811-22. PMID 23306863 DOI: 10.1007/S00262-012-1389-Z |
0.275 |
|
| 2012 |
Frleta D, Ochoa CE, Kramer HB, Khan SA, Stacey AR, Borrow P, Kessler BM, Haynes BF, Bhardwaj N. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. The Journal of Clinical Investigation. 122: 4685-97. PMID 23160198 DOI: 10.1172/Jci64439 |
0.264 |
|
| 2023 |
Patel AK, Dhanik A, Lim WK, Adler C, Ni M, Wei Y, Zhong M, Nguyen C, Zhong J, Lu YF, Thurston G, Macdonald L, Murphy A, Gurer C, Frleta D. Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model. Communications Biology. 6: 444. PMID 37087494 DOI: 10.1038/s42003-023-04824-z |
0.253 |
|
| 2023 |
Gao J, Ren S, Choonoo G, Chen G, Frleta D, Zhong J, Gupta N, Sharma P, Oyejide A, Atwal GS, Macdonald L, Murphy A, Kuhnert F. Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice. Disease Models & Mechanisms. PMID 37718909 DOI: 10.1242/dmm.050190 |
0.23 |
|
| 2017 |
Herndler-Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, Strowig T, de Zoete MR, Palm NW, Chen J, Blish CA, Frleta D, Gurer C, Macdonald LE, Murphy AJ, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 29078283 DOI: 10.1073/Pnas.1705301114 |
0.223 |
|
| 2000 |
Barchowsky A, Frleta D, Vincenti MP. Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: Divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts Cytokine. 12: 1469-1479. PMID 11023661 DOI: 10.1006/Cyto.2000.0743 |
0.206 |
|
| 2011 |
Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nature Reviews. Immunology. 11: 176-86. PMID 21350578 DOI: 10.1038/Nri2935 |
0.201 |
|
| 2014 |
Manches O, Frleta D, Bhardwaj N. Dendritic cells in progression and pathology of HIV infection. Trends in Immunology. 35: 114-22. PMID 24246474 DOI: 10.1016/J.It.2013.10.003 |
0.196 |
|
| 2012 |
Miller EA, Spadaccia MR, OʼBrien MP, Rolnitzky L, Sabado R, Manches O, Frleta D, Bhardwaj N. Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 535-44. PMID 22902724 DOI: 10.1097/Qai.0B013E31826Afbce |
0.193 |
|
| 2023 |
Carbonaro M, Wang K, Huang H, Frleta D, Patel A, Pennington A, Desclaux M, Moller-Tank S, Grindley J, Altarejos J, Zhong J, Polites G, Poueymirou W, Jaspers S, Kyratsous C, et al. IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models. Science Advances. 9: eadf4490. PMID 37058568 DOI: 10.1126/sciadv.adf4490 |
0.182 |
|
| 2006 |
Saito H, Frleta D, Dubsky P, Palucka AK. Dendritic cell-based vaccination against cancer. Hematology/Oncology Clinics of North America. 20: 689-710. PMID 16762730 DOI: 10.1016/J.Hoc.2006.02.011 |
0.171 |
|
| 2014 |
Frleta DS. Island destinations' tourism offer-tourists' vs. residents' attitudes Tourism and Hospitality Management. 20: 1-14. |
0.067 |
|
| Hide low-probability matches. |